NCT Number: NCT00006429
Treadmill Training for Spinal Cord Injury
This is a trial to test whether treadmill training can be used to improve the "walking" of patients with partial spinal cord injury. While on the treadmill, patients will be partially supported through the use of a specially designed harness attached to an overhead lift (also called Body Weight Supported Treadmill Training, BWSTT). Patients who enroll in this study will be randomly assigned to either the experimental group, which receives 12 weeks of this specialized treadmill training with regular physical therapy, or to the control group, which receives 12 weeks regular physical therapy. The ability of the patients to "walk" will be measured before and after treatment as well as 6 and 12 months later, using standard tests that examine mobility independence and speed of ambulation. The trial takes place across five sites in the US and Canada. Patients eligible for this trial will have had a traumatic spinal cord injury within 8 weeks of trial entry.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
University of Ottawa, Ottawa, Ontario, Canada
About this study
This is a 5-site randomized clinical trial of a task-oriented locomotor intervention for acute spinal cord injury (SCI). The intervention, body weight-supported treadmill training (BWSTT), partially supports the weight of the patient via an overhead lift attached to a harness. Therapists train the patient to walk on a treadmill by correcting gait deviations and manipulating sensory input that enhance control of the stance and swing phases of walking at increasingly higher speeds and less weight support. 100 patients with incomplete SCI (from below C4 to T10/11) and 100 patients with lesions at T12 to L3 will be randomly assigned to 12 weeks of conventional therapy programs for mobility versus the same intensity and duration of a combination of conventional therapy plus BWSTT. The primary outcome measures are the level of independence for ambulation and the maximal speed for walking 50 feet. Patients will be tested by masked examiners before and after the 12 weeks of therapy, and 6 and 12 months after entry into the study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Traumatic spinal cord injury (within 56 days)
- Incomplete lesion: - ASIA C or D, from below C4 to L3 - ASIA B at or below C7
- Unable to ambulate over ground without at least moderate assistance (FIM locomotor 3 or less)
- Able to offer at least 3/5 strength in elbow extensors
- No clinically-significant cognitive impairment
Exclusion criteria
- Symptomatic fall in blood pressure greater than 30 mm Hg when upright
- Halo or other cervical brace or TLSO (unless primary surgeon agrees)
- Contraindication to weight bearing on lower extremities
- Pressure sore with any skin breakdown below level of the SCI
- Any debilitating disease prior to the acute SCI that would cause exercise intolerance
- Premorbid, ongoing major depression or psychosis
- Required use of anti-spasticity medication
- Subject unlikely to complete intervention or return for follow-up
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Nih
Registry information
Official study title
Locomotor Therapy Trial for Spinal Cord Injury
Important dates
- Study start
- 1999
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Nov 2, 2000
- Registry last updated
- Sep 26, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Turkish Version of the Neurogenic Bladder Symptom Score Short Form
NCT07507331
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsSpinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain
NCT05433064
Central Nervous System Diseases, Nervous System Diseases
Hualien City, Taiwan
View Trial DetailsEpidural Stimulation and Rehabilitation for Spinal Cord Injury
NCT07717606
Central Nervous System Diseases, Conus Medullaris Injury
Istanbul, Turkey (Türkiye)
View Trial DetailsAssessing Transition Practices for Children With Disabilities: Pathways to a Successful Adulthood
NCT07706517
Brain Damage, Chronic, Brain Diseases
Saint-Etienne, France
View Trial Details